ライフサイエンスコーパス: melanocyte-stimulating hormone

1 ned with a selective MC3-R agonist (gamma(2)-melanocyte-stimulating hormone).

2 ormone = adrenocorticotropic hormone > gamma-melanocyte-stimulating hormone).

3 asopressin, agouti-related protein and alpha-melanocyte stimulating hormone.

4 mentation does not appear to be regulated by melanocyte stimulating hormone.

5 ed how these responses are affected by alpha-melanocyte-stimulating hormone.

6 ction but this response was reduced by alpha-melanocyte-stimulating hormone.

7 e levels were increased in response to alpha-melanocyte-stimulating hormone.

8 mulation of tyrosinase gene transcription by melanocyte-stimulating hormone.

9 re found to be enhanced by addition of alpha-melanocyte-stimulating hormone.

10 d the positive effects of [Nle, D-Phe]-alpha-melanocyte-stimulating hormone.

11 table levels of adrenocorticotropin or alpha-melanocyte-stimulating hormone.

12 ucagon and proopiomelanocortin-derived alpha-melanocyte-stimulating hormone.

13 on stimulation with its natural ligand alpha-melanocyte-stimulating hormone.

14 We report that alpha-melanocyte-stimulating hormone (10-9 M) was effective in

15 h a selective MC3R agonist ([D-Trp(8)]-gamma-melanocyte-stimulating hormone; 10 microg i.v.) produced

16 des alpha-melanocyte-stimulating hormone and melanocyte-stimulating hormone 11-13 (KP-D-V) on the inv

17 nt in the aqueous humor (10-9 M), as well as melanocyte-stimulating hormone 11-13 (KP-D-V) reduced th

18 (188)Re-(Arg(11))[Cys(3,4,10),d-Phe(7)]alpha-melanocyte-stimulating hormone(3-13) (CCMSH) in the B16/

19 rahydrobiopterin resulting in a stable alpha-melanocyte stimulating hormone/6(R)-L-erythro 5,6,7,8 te

20 cid, and niacinamide) and stimulators (alpha-melanocyte-stimulating hormone, 8-methoxypsoralen, and 3

21 nistration of the endogenous MC4R agonist, a-melanocyte stimulating hormone (a-MSH), triggers the rel

22 Alpha-melanocyte-stimulating hormone (a-MSH) is a neuropeptide

23 o-opiomelanocortin (POMC, the precursor of a-melanocyte stimulating hormone [a-MSH]) in hypothalamic

24 bitor of rac1 abrogated the ability of alpha-melanocyte stimulating hormone, a peptide hormone known

25 One such factor is alpha-melanocyte-stimulating hormone, a potent anti-inflammato

26 f the melanotropin peptides alpha-MSH (alpha-melanocyte-stimulating hormone, Ac-Ser-Tyr-Met-Glu- His-

27 his study provides further evidence of alpha-melanocyte stimulating hormone acting to "protect" melan

28 similar in these two species homologs (alpha-melanocyte-stimulating hormone = adrenocorticotropic hor

29 For this purpose antibodies against alpha-melanocyte stimulating hormone, adrenocorticotropin, pro

30 When treated with a stable alpha-melanocyte-stimulating hormone agonist, mutant mice lost

31 r evaluation of PDE4is with or without alpha-melanocyte-stimulating hormone agonists in vitiligo tria

32 eceptor its and adrenocorticotropic hormone, melanocyte stimulating hormone, agouti protein ligands (

33 alpha-Melanocyte stimulating hormone (alpha-MSH) analogs, cycl

34 ts of two melanocortin system ligands, alpha melanocyte stimulating hormone (alpha-MSH) and agouti-re

35 The regulated release of anorexigenic alpha-melanocyte stimulating hormone (alpha-MSH) and orexigeni

36 The peptides alpha-melanocyte stimulating hormone (alpha-MSH) and oxytocin,

37 ic hormone (ACTH), beta-endorphin, and alpha-melanocyte stimulating hormone (alpha-MSH) are synthesiz

38 n the ARC, IRS-2 was co-localized with alpha melanocyte stimulating hormone (alpha-MSH) as well as ne

39 orms act as competitive antagonists of alpha-melanocyte stimulating hormone (alpha-MSH) at melanocort

40 ne whether the neuroprotective peptide alpha-melanocyte stimulating hormone (alpha-MSH) attenuates GA

41 Alpha-melanocyte stimulating hormone (alpha-MSH) has pigmentar

42 potential application of neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) in mitigating

43 ulated transcript (CART) coexists with alpha-melanocyte stimulating hormone (alpha-MSH) in the arcuat

44 leus (ARC), and on opioid peptides and alpha-melanocyte stimulating hormone (alpha-MSH) in the parave

45 alpha-melanocyte stimulating hormone (alpha-MSH) is a melanoco

46 alpha-Melanocyte stimulating hormone (alpha-MSH) is a neuropep

47 Alpha-melanocyte stimulating hormone (alpha-MSH) is an anorexi

48 The neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is an importa

49 lanocortin (POMC)-derived neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is known to m

50 Alpha-melanocyte stimulating hormone (alpha-MSH) is one of the

51 ms underlying the effects of intra-VTA alpha-melanocyte stimulating hormone (alpha-MSH) on feeding an

52 compared with four other radiolabeled alpha-melanocyte stimulating hormone (alpha-MSH) peptide analo

53 sp-conjugated and X-Ala-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptides.

54 w (99m)Tc-labeled Arg-X-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptides.

55 a prevention based on using analogs of alpha-melanocyte stimulating hormone (alpha-MSH) that function

56 The pro-opiomelanocortin product alpha-melanocyte stimulating hormone (alpha-MSH), an MC3/4-R a

57 The concentration of PRL, alpha-melanocyte stimulating hormone (alpha-MSH), and luteiniz

58 age chemoattractant protein-1 (MCP-1), alpha-melanocyte stimulating hormone (alpha-MSH), and peroxiso

59 ReCCMSH(Arg(11)), a cyclic analogue of alpha-melanocyte stimulating hormone (alpha-MSH), exhibited hi

60 tor (CRF) might be mediated via MC4-R. alpha-Melanocyte stimulating hormone (alpha-MSH), the MC4-R ag

61 ing the production of the MC4R ligand, alpha-melanocyte stimulating hormone (alpha-MSH), to regulate

62 C4-R agonists, melanotan-II (MT-II) or alpha-melanocyte stimulating hormone (alpha-MSH), were unilate

63 s are stimulated by the native ligand, alpha-melanocyte stimulating hormone (alpha-MSH).

64 stimulated by the melanocortin agonist alpha-melanocyte stimulating hormone (alpha-MSH).

65 ARC(POMC) neuron-derived MC4R agonist, alpha-melanocyte stimulating hormone (alpha-MSH).

66 ls was blocked by co-administration of alpha-melanocyte stimulating hormone (alpha-MSH, 20 ng), a hor

67 tivity of leptin, the leptin receptor, alpha-melanocyte stimulating hormones (alpha-MSH) and the mela

68 er the functional IL-1beta antagonist, alpha-melanocyte-stimulating hormone (alpha-MSH(1-13)), would

69 ibution, and clearance kinetics of the alpha-melanocyte-stimulating hormone (alpha-MSH) analog 1,4,7,

70 Radiohalogenated alpha-melanocyte-stimulating hormone (alpha-MSH) analogs were

71 eport in vitro and in vivo data of new alpha-melanocyte-stimulating hormone (alpha-MSH) analogues whi

72 NPY) and anorexigenic peptides such as alpha-melanocyte-stimulating hormone (alpha-MSH) and anorexige

73 d plasma and cerebrospinal fluid (CSF) alpha-melanocyte-stimulating hormone (alpha-MSH) and beta-endo

74 n, resulting in selective increases of alpha-melanocyte-stimulating hormone (alpha-Msh) and carboxy-c

75 ein-coupled receptor (GPCR) that binds alpha-melanocyte-stimulating hormone (alpha-MSH) and has a cen

76 The neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) and its C-ter

77 he melanocortin system, which includes alpha-melanocyte-stimulating hormone (alpha-MSH) and its endog

78 ese proteins antagonize the effects of alpha-melanocyte-stimulating hormone (alpha-MSH) and other mel

79 ng effects of the anorexigenic agonist alpha-melanocyte-stimulating hormone (alpha-MSH) and the orexi

80 MC4R responds to an agonist, alpha-melanocyte-stimulating hormone (alpha-MSH) and to an ant

81 We have previously shown that alpha-melanocyte-stimulating hormone (alpha-MSH) can oppose tu

82 ntake and PK2 increased the release of alpha-melanocyte-stimulating hormone (alpha-MSH) from ex vivo

83 gated the efficacy of the neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) in promoting

84 recordings revealed that both NPY and alpha-melanocyte-stimulating hormone (alpha-MSH) inhibit and s

85 Alpha-melanocyte-stimulating hormone (alpha-MSH) is a neuropep

86 alpha-Melanocyte-stimulating hormone (alpha-MSH) is a potent a

87 Alpha-melanocyte-stimulating hormone (alpha-MSH) is a tridecap

88 Alpha-melanocyte-stimulating hormone (alpha-MSH) is an antiinf

89 the appetite-suppressing neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) is reduced, y

90 TH) of pars distalis corticotropes and alpha-melanocyte-stimulating hormone (alpha-MSH) of pars inter

91 s study aimed at revealing the role of alpha-melanocyte-stimulating hormone (alpha-MSH) on basophil f

92 We report that melanocyte-stimulating hormone (alpha-MSH) or ACTH induc

93 melanocortin receptor agonists such as alpha-melanocyte-stimulating hormone (alpha-MSH) or antagonist

94 phage that displayed up to 5 copies of alpha-melanocyte-stimulating hormone (alpha-MSH) peptide analo

95 he radiolabeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone (alpha-MSH) peptide on it

96 e whether (99m)Tc- and (111)In-labeled alpha-melanocyte-stimulating hormone (alpha-MSH) peptides coul

97 ) neurons and the POMC-derived peptide alpha-melanocyte-stimulating hormone (alpha-MSH) promote satie

98 The alpha-melanocyte-stimulating hormone (alpha-MSH) receptor (mel

99 type 1 receptor (MC1R), also known as alpha-melanocyte-stimulating hormone (alpha-MSH) receptor, is

100 ion (suntanning) requires induction of alpha-melanocyte-stimulating hormone (alpha-MSH) secretion by

101 Activation of MC1R in melanocytes by alpha-melanocyte-stimulating hormone (alpha-MSH) stimulates cA

102 The pituitary peptide alpha-melanocyte-stimulating hormone (alpha-MSH) stimulates me

103 Reduction in the activity of the alpha-melanocyte-stimulating hormone (alpha-MSH) system causes

104 prolylcarboxypeptidase (PRCP) degrades alpha-melanocyte-stimulating hormone (alpha-MSH) to an inactiv

105 t color by antagonizing the binding of alpha-melanocyte-stimulating hormone (alpha-MSH) to the alpha-

106 us of the hypothalamus (PVN), to block alpha-melanocyte-stimulating hormone (alpha-MSH) type 3 and 4

107 1R, inhibiting the alpha-melanocortin (alpha-melanocyte-stimulating hormone (alpha-MSH))-induced incr

108 elanocortin 4 (MC-4) receptors such as alpha-melanocyte-stimulating hormone (alpha-MSH), a product of

109 in the regulation of feeding by using alpha-melanocyte-stimulating hormone (alpha-MSH), an endogenou

110 -tetraacetic acid), a cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), has the pote

111 nd regulating release of products like alpha-melanocyte-stimulating hormone (alpha-MSH), neuropeptide

112 re potent appetite stimulants, whereas alpha-melanocyte-stimulating hormone (alpha-MSH), neurotensin,

113 ither a melanocortin receptor agonist, alpha-melanocyte-stimulating hormone (alpha-MSH), or antagonis

114 (NDP-MSH), a highly potent analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), possesses na

115 designed to examine the evidence that alpha-melanocyte-stimulating hormone (alpha-MSH), which is tho

116 group of Lys(10) of the cyclic lactam alpha-melanocyte-stimulating hormone (alpha-MSH)-derived Pro(6

117 both direct and indirect regulation by alpha melanocyte-stimulating hormone (alpha-MSH)-synthesizing

118 roach, we produced biologically active alpha-melanocyte-stimulating hormone (alpha-MSH).

119 ty of the receptor to bind its ligand, alpha-melanocyte-stimulating hormone (alpha-MSH).

120 irculating and lesional skin levels of alpha-melanocyte-stimulating hormone (alpha-MSH).

121 ce or absence of stimulation by the agonist, melanocyte-stimulating hormone (alpha-MSH).

122 ting mPOMC was converted to des-acetyl alpha-melanocyte-stimulating hormone (alpha-MSH).

123 The anorexigenic neuromodulator alpha-melanocyte-stimulating hormone (alpha-MSH; referred to h

124 esis through which ultraviolet (UV) or alpha-melanocyte-stimulating hormones (alpha-MSH) stimuli act

125 ocked by 2 different IL-1 antagonists, alpha melanocyte stimulating hormone (alphaMSH) and interleuki

126 that physiological melanogenic stimuli alpha-melanocyte stimulating hormone (alphaMSH) increases STIM

127 Physiologically activated by alpha-melanocyte stimulating hormone (alphaMSH), MC1R function

128 resembling mice with reduced action of alpha melanocyte stimulating hormone (alphaMSH).

129 melanoma cells synthesize and release alpha-melanocyte stimulating hormone (alphaMSH, the ligand for

130 havior of these cells is influenced by alpha-melanocyte-stimulating hormone (alphaMSH) and melanin-co

131 The POMC-derived peptide alpha-melanocyte-stimulating hormone (alphaMSH) is a melanocor

132 erestingly, hypothalamic Pomc mRNA and alpha-melanocyte-stimulating hormone (alphaMSH) peptide levels

133 alpha-Melanocyte-stimulating hormone also increased the levels

134 the rise in cAMP levels in response to alpha-melanocyte-stimulating hormone, an MC4R agonist, by bloc

135 ich can be achieved using radiolabeled alpha-melanocyte-stimulating hormone analog NAPamide derivativ

136 ce with DIO to treatment with MTII, an alpha-melanocyte-stimulating hormone analog.

137 ions did not affect the ability of the alpha-melanocyte stimulating hormone analogue [Nle4,D-Phe7] me

138 An alpha-melanocyte-stimulating hormone analogue can reduce sunli

139 valuated the safety and efficacy of an alpha-melanocyte-stimulating hormone analogue, afamelanotide,

140 The presence of alpha-melanocyte stimulating hormone and adrenocorticotropin i

141 dendrite formation in B16F1 cells, and alpha-melanocyte stimulating hormone and ultraviolet light sti

142 ac1 mediates the well-known ability of alpha-melanocyte stimulating hormone and ultraviolet light to

143 We used known melanogenic stimulators (alpha-melanocyte-stimulating hormone and 3,4-dihydroxyphenylal

144 lanocortin peptides alpha-, beta-, and gamma-melanocyte-stimulating hormone and ACTH are full agonist

145 alpha-Melanocyte-stimulating hormone and adrenocorticotropic h

146 e proopiomelanocortin-derived peptides alpha-melanocyte-stimulating hormone and beta-endorphin, the g

147 enic neuropeptides pro-opiomelanocortinalpha-melanocyte-stimulating hormone and cocaine-amphetamine-r

148 and anorexigenic (pro-opiomelanocortinalpha-melanocyte-stimulating hormone and cocaine-amphetamine-r

149 Both central alpha-melanocyte-stimulating hormone and corticotropin-releasi

150 of the proopiomelanocortin-derived peptides melanocyte-stimulating hormone and corticotropin.

151 ontraction in melanocytes, mediated by alpha-melanocyte-stimulating hormone and melanin-concentrating

152 and of the anti-inflammatory peptides alpha-melanocyte-stimulating hormone and melanocyte-stimulatin

153 -derived macrophages, we observed that alpha-melanocyte-stimulating hormone and selective MC1-R agoni

154 wn that a cell-permeable peptide, a hormone (melanocyte stimulating hormone), and a blood-clotting ag

155 tra of the model peptides (bradykinin, alpha-melanocyte stimulating hormone, and melittin) change sig

156 omelanocortin (POMC)-derived peptides, alpha-melanocyte-stimulating hormone, and adrenocorticotropic

157 rphin A-17, a decrease in the level of alpha-melanocyte-stimulating hormone, and an alteration in the

158 encodes both the anorexigenic peptide alpha-melanocyte-stimulating hormone, and the opioid peptide b

159 including arbutin, hydroquinone, kojic acid, melanocyte-stimulating hormone, and thymidine dimers) as

160 adrenocorticotropin, alpha-, beta- and gamma-melanocyte stimulating hormone; and the endogenous opioi

161 to investigate the mechanism by which alpha-melanocyte-stimulating hormone antagonizes proinflammato

162 and that the anti-invasive actions of alpha-melanocyte stimulating hormone are consistent with its w

163 Adrenocorticotropic hormone and alpha-melanocyte stimulating hormone are derived from pro-opio

164 hormone, beta-lipotropic hormone, and alpha-melanocyte-stimulating hormone are also derived.

165 stochastic carcinogenesis and identify alpha-melanocyte-stimulating hormone as a potential attenuatin

166 Additionally, our results identify alpha-melanocyte-stimulating hormone as a potential mediator o

167 s through the blockade of signaling by alpha-melanocyte-stimulating hormone at central nervous system

168 and potency of the endogenous agonist alpha-melanocyte-stimulating hormone at the MC4R by 37- and 60

169 Full-length alpha-melanocyte-stimulating hormone, at concentrations presen

170 Notably, the density of anorexigenic alpha-melanocyte-stimulating hormone axons was reduced in adul

171 s of novel, disulfide-constrained human beta-melanocyte stimulating hormone (beta-MSH)-derived peptid

172 rupts the dibasic cleavage site between beta melanocyte-stimulating hormone (beta-MSH) and beta-endor

173 in (POMC), which prevents production of beta-melanocyte-stimulating hormone (beta-MSH) and beta-endor

174 Here, we show that the peptide beta-melanocyte-stimulating hormone (beta-MSH) is cleaved by

175 ptides include adrenocorticotrophic hormone, melanocyte stimulating hormone, beta-lipotrophin, and th

176 e precursor for adrenocorticotropic hormone, melanocyte-stimulating hormones, beta-lipotropic hormone

177 prevented the inhibitory actions of gamma(2)-melanocyte stimulating hormone both in vitro and in vivo

178 by the more selective MC3-R agonist gamma(2)-melanocyte stimulating hormone but not by the selective

179 n S-91 mouse melanoma cells respond to alpha-melanocyte-stimulating hormone) by demonstrating a marke

180 Recently, it has been shown that alpha-melanocyte stimulating hormone can directly activate tyr

181 ear run-off transcription assays showed that melanocyte-stimulating hormone caused a slow increase in

182 mers with different molecular sizes, [d-Trp]-melanocyte-stimulating hormone, [d-Ala]-deltorphin, [d-P

183 At concentrations in excess of 10-9 M alpha-melanocyte-stimulating hormone decreased nitric oxide pr

184 cell surface, but it does not restore alpha-melanocyte-stimulating hormone-dependent cAMP signaling.

185 Tc(CO)3-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone derivative, betaAlaNleCyc

186 hat inhibits the binding and action of alpha-melanocyte-stimulating hormone derived from proopiomelan

187 ow report that treatment of melanocytes with melanocyte-stimulating hormone down-regulates expression

188 melanoma cells were exposed continuously to melanocyte-stimulating hormone for 6 d, a large but tran

189 alpha-melanocyte-stimulating hormone from arcuate POMC neurons

190 The gamma-melanocyte-stimulating hormone (gamma-MSH) is a natriure

191 rly to the previously described cyclic gamma-melanocyte-stimulating hormone (gamma-MSH)-derived hMC3R

192 at each position of the short peptide gamma-melanocyte-stimulating hormone (gamma-MSH).

193 gamma-MSH (gamma-melanocyte-stimulating hormone, H-Tyr-Val-Met-Gly-His-Ph

194 These data show that alpha-melanocyte-stimulating hormone has a pronounced effect o

195 alpha-Melanocyte-stimulating hormone, however, decreased induc

196 minase-containing neurons) but not others (a-melanocyte-stimulating hormone), indicating specificity

197 te was unaffected by treatment of cells with melanocyte-stimulating hormone, indicating that the horm

198 Melanocyte-stimulating hormone-induced expression of MIT

199 ment with cycloheximide had no effect on the melanocyte-stimulating hormone-induced increase in tyros

200 In cultured hypothalamic neurons, melanocyte stimulating hormone induces an MC4R-dependent

201 opiomelanocortin (POMC) that is processed to melanocyte-stimulating hormone, inducing tanning.

202 (dynorphin A-17, beta-endorphin, and alpha- melanocyte-stimulating hormone) involved in the control

203 oduction by melanocytes in response to alpha-melanocyte-stimulating hormone is associated with such a

204 Alpha-melanocyte-stimulating hormone is produced by several di

205 Afamelanotide, an analogue of alpha-melanocyte-stimulating hormone, is known to induce tanni

206 n of the fibroblast growth factor (FGFR) and melanocyte stimulating hormone (MC1R) receptors stimulat

207 grin expression and ask to what extent alpha-melanocyte stimulating hormone might protect cells from

208 two intercellular signaling molecules, alpha-melanocyte stimulating hormone (MSH) and agouti signal p

209 uces activation of regulatory T cells, alpha-melanocyte stimulating hormone (MSH) and transforming gr

210 uggested a critical role for the MC1R ligand melanocyte stimulating hormone (MSH) in this response, a

211 ignaling either by the agonistic MC1R ligand melanocyte stimulating hormone (MSH) or by pharmacologic

212 Melanocyte stimulating hormone (MSH) plays an important

213 , from the absence of induction by leptin of melanocyte stimulating hormone (MSH) secretion in the hy

214 gmentation in mammals is stimulated by alpha-melanocyte stimulating hormone (MSH), which binds to the

215 ropic hormone, and alpha-, beta-, and gamma- melanocyte stimulating hormone (MSH).

216 nocortin (MC) receptor agonist DTrp(8)-gamma-melanocyte stimulating hormone (MSH; DTrp).

217 s agonists such as alpha-, beta-, and gamma2-melanocyte stimulating hormones (MSH) and adrenocorticot

218 genous agonists [alpha-, beta-, and gamma(2)-melanocyte stimulating hormones (MSH) and adrenocorticot

219 ptor agonists including alpha-, beta-, gamma-melanocyte stimulating hormones (MSH) and adrenocorticot

220 he intermediate lobe melanotropes, producing melanocyte-stimulating hormone (MSH alpha), have remaine

221 two intercellular signaling molecules, alpha-melanocyte-stimulating hormone (MSH) and agouti signal p

222 r MMS increases the response of S91 cells to melanocyte-stimulating hormone (MSH) and increases the b

223 the selective MC3R agonist [d-Trp(8)]-gamma-melanocyte-stimulating hormone (MSH) and of the recessiv

224 may mediate the hypophagic effects of alpha-melanocyte-stimulating hormone (MSH) in the rat.

225 mes in melanocytes, whereas treatment with a-melanocyte-stimulating hormone (MSH) induced exocytosis

226 zed rats, unilateral microinjection of alpha-melanocyte-stimulating hormone (MSH) into the medullary

227 Alpha-Melanocyte-stimulating hormone (MSH) is a potent anti-in

228 oopiomelanocortin transcription and systemic melanocyte-stimulating hormone (MSH) levels in the plasm

229 Melanocyte-stimulating hormone (MSH) peptides processed

230 Melanocyte-stimulating hormone (MSH) plays a crucial rol

231 Melanocyte-stimulating hormone (MSH) promotes transcript

232 scopic visualization and characterization of melanocyte-stimulating hormone (MSH) receptors of melano

233 Melanocyte-stimulating hormone (MSH) reduces UV-induced

234 alpha-Melanocyte-stimulating hormone (MSH) utilizes cAMP to tr

235 alpha-Melanocyte-stimulating hormone (MSH), a stimulus which i

236 e and functionality of ACTH, alpha- and beta-melanocyte-stimulating hormone (MSH), and beta-endorphin

237 ion throughout the cytoplasm is triggered by melanocyte-stimulating hormone (MSH), with both of these

238 melatonin, whereas dispersion is induced by melanocyte-stimulating hormone (MSH).

239 ticotropic hormone, beta-lipotropin, and the melanocyte-stimulating hormones (MSH), which act through

240 omplete loss of both [Nle(4)-d-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) binding and NDP

241 activity studies of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) identified D-Ph

242 uti-related protein (AGRP)/[Nle4,DPhe7]alpha-melanocyte stimulating hormone (NDP-MSH) ligands is repo

243 rotective effect of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH), a potent non-s

244 [Nle(4),d-Phe(7)]-alpha-melanocyte-stimulating hormone (NDP-alpha-MSH) labeled w

245 g assays for agonist, [Nle(4)-d-Phe(7)]alpha-melanocyte-stimulating hormone (NDP-alpha-MSH) or forsko

246 human MC4R activation by [Nle4, d-Phe7]alpha-melanocyte-stimulating hormone (NDP-MSH), by first defin

247 oximity to the bound ligand [Nle(4),D-Phe(7)]melanocyte-stimulating hormone (NDP-MSH), thereby differ

248 neuropeptide glutamic acid-isoleucine/alpha-melanocyte-stimulating hormone (NEI/alphaMSH) peptides.

249 were carried out to determine the effect of melanocyte-stimulating hormone on tyrosinase gene transc

250 (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptides.

251 grown in the presence of 10-11-10-9 M alpha-melanocyte-stimulating hormone prior to stimulation.

252 gh actions on TRH neurons, addition of alpha-melanocyte-stimulating hormone produced a 3.5-fold incre

253 ultures prepared from 7B2 null mice restored melanocyte-stimulating hormone production, substantiatin

254 the expression of proopiomelanocortin/alpha-melanocyte-stimulating hormone, provoked by C75 and reve

255 Allelic variation at the melanocyte stimulating hormone receptor (MC1R) gene has

256 e mutation in a classical pigmentation gene, melanocyte stimulating hormone receptor (MC1R), is stron

257 e skin, is a high-affinity antagonist of the melanocyte-stimulating hormone receptor (MC1-R), thus ex

258 aberrantly antagonizes the MC4-R, a related melanocyte-stimulating hormone receptor expressed in hyp

259 that modifies coat color by antagonizing the melanocyte-stimulating hormone receptor or MC1-R.

260 d to image melanoma through targeting of the melanocyte-stimulating hormone receptor.

261 alpha-melanocyte--stimulating hormone to the melanocyte-stimulating--hormone receptor (MSHR), the pro

262 ologies concerning cells which express alpha-melanocyte-stimulating hormone receptors and utilize the

263 In contrast, alpha-melanocyte stimulating hormone reduced cell attachment,

264 icotropin-releasing factor, leptin and alpha-melanocyte stimulating hormone regulate cytokine balance

265 These results suggest that alpha-melanocyte-stimulating hormone regulates nitric oxide pr

266 mic explants but significantly reduced alpha melanocyte stimulating hormone release in vitro.

267 ature just before light onset, whereas alpha-melanocyte stimulating hormone release, especially at th

268 ively increases beta-endorphin but not alpha-melanocyte-stimulating hormone release in the hypothalam

269 mediating immunomodulatory actions of alpha-melanocyte-stimulating hormone remains to be seen.

270 y, whereas receptor binding with the agonist melanocyte-stimulating hormone resulted in an increased

271 lity complex class I and downregulated alpha-melanocyte-stimulating hormone, signifying immune privil

272 h the melanocortin analog [Nle, D-Phe]-alpha-melanocyte-stimulating hormone (starting 3 or 6 hrs afte

273 ndothelin 1, hepatocyte growth factor, alpha-melanocyte stimulating hormone, stem cell factor, and fi

274 Neuropeptide Y (NPY) inhibited and alpha-melanocyte-stimulating hormone stimulated ARC glucose-ex

275 rease in tyrosinase mRNA occurred 60 h after melanocyte-stimulating hormone stimulation and was follo

276 tial glands of rodents is regulated by alpha-melanocyte stimulating hormone, the major agonist for me

277 ith the regulation of melanogenesis by alpha-melanocyte-stimulating hormone through melanocortin 1 re

278 e stimulating hormone analogue [Nle4,D-Phe7] melanocyte stimulating hormone to bind or activate the c

279 tern immunoblotting and the ability of alpha-melanocyte stimulating hormone to oppose the actions of

280 We have previously shown alpha-melanocyte stimulating hormone to protect melanocytes an

281 In mice and humans, binding of alpha-melanocyte--stimulating hormone to the melanocyte-stimul

282 of NF-kappaB DNA binding activity with alpha-melanocyte-stimulating hormone was detected 2 h after ce

283 n cAMP in response to stimulation with alpha-melanocyte-stimulating hormone was measured in HEK-293 c

284 vating cyclic adenosine monophosphate, alpha-melanocyte-stimulating hormone was not found to have any

285 appear to be physiological targets of alpha-melanocyte-stimulating hormone, which inhibits food inta

286 d tumorigenicity assays indicates that alpha-melanocyte-stimulating hormone, which is overproduced by

287 onses to the cAMP agonists cholera toxin and melanocyte-stimulating hormone, which normally promote m

288 ch aims to maintain high urine output; alpha-melanocyte-stimulating hormone, with anti-inflammatory a

289 and in a subset of cells coexpressing alpha-melanocyte-stimulating hormone within the pituitary pars